Remote Oxygen Monitoring for Premature Babies With Lung Disease
Tests remote monitoring of oxygen levels in premature infants with lung disease and pulmonary hypertension.
Plain-language title generated from the registry record
Registry title: Controlled Remote Monitoring and Optimization of Oxygen Therapy in Preterm Infants
Key facts
- Where
- České Budějovice, Olomouc, and Prague, CzechiaSee the 4 sites
Where in Czechia
- České Budějovice HospitalČeské Budějovice, CzechiaTaking people
- University Hospital OlomoucOlomouc, CzechiaTaking people
- General University HospitalPrague, CzechiaTaking people
- Institute for the Care of Mother and ChildPrague, CzechiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Institute of Health Information and Statistics of the Czech Republic
- Trial code
- NCT07161908
- Record updated
- 3 November 2026
- Original description
The project is a national, prospective, multicenter, interventional pilot project focused on controlled remote monitoring and optimization of oxygen therapy for premature infants in the Czech Republic. The primary aim of the project is to prepare, test, and develop a proposal for a national methodology for the care of preterm newborns. This will reduce health risks in premature infants and minimize the negative impacts on the overall development of the child and the family of the premature infant.Read full original descriptionShow less
Early Detection and Prevention of Health Complications in Preterm Infants - Controlled Remote Monitoring and Optimization of Oxygen Therapy
The project is a national, prospective, multicenter, interventional pilot project focused on controlled remote monitoring and optimization of oxygen therapy for premature infants in the Czech Republic. The primary aim of the project is to prepare, test, and develop a proposal for a national methodology for the care of preterm newborns. This will reduce health risks in premature infants and minimize the negative impacts on the overall development of the child and the family of the premature infant.
Inclusion: infants born before 31+6 weeks gestation; signed consent for participation in the project and consent for the processing of personal data; diagnosed with bronchopulmonary dysplasia; type of pulmonary ventilation - low-flow nasal cannulas.
Exclusion: insufficient therapy through long-term home oxygen therapy; child diagnosed with conditions other than bronchopulmonary dysplasia (BPD) at high risk of long-term hypoxia - selected chronic cardiovascular, neurological, and muscular diseases, e.g., significant congenital heart defects, congenital central nervous system developmental disorders, genetic diseases associated with the risk of hypoventilation, central apneas, severe early obstructive sleep apnea; other chronic respiratory diseases besides BPD - e.g., cystic fibrosis, chronic aspiration; unsigned consent for participation in the project and/or consent for the processing of personal data; tracheostomy.